Tummala P E, Chen X L, Sundell C L, Laursen J B, Hammes C P, Alexander R W, Harrison D G, Medford R M
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Circulation. 1999 Sep 14;100(11):1223-9. doi: 10.1161/01.cir.100.11.1223.
Cardiovascular ischemic events may occur more frequently in hypertensive patients with activated renin-angiotensin systems. We tested the hypothesis that angiotensin II (Ang II) may contribute to atherosclerosis by increasing expression of vascular inflammatory genes such as vascular cell adhesion molecule-1 (VCAM-1).
Rats infused with norepinephrine or Ang II for 6 days developed similar hypertensive responses, but only Ang II-treated rats exhibited significant increases in aortic VCAM-1 protein and mRNA expression. Oral losartan treatment (50 mg. kg(-1). d(-1)) inhibited Ang II-induced hypertension and aortic VCAM-1 mRNA expression. Ang II treatment significantly increased VCAM-1 mRNA expression in cultured rat aortic smooth muscle cells (RASMCs). Ang II also induced nuclear NF-kappaB-like binding activity and transactivated an NF-kappaB-driven VCAM-1 promoter. Losartan and proteasome inhibitors blocked Ang II-induced NF-kappaB activation and VCAM-1 mRNA accumulation. IkappaB-alpha overexpression in RASMCs inhibited Ang II-induced VCAM-1 promoter transactivation.
Ang II may contribute to atherogenesis by activation of VCAM-1 through proteasome dependent, NF-kappaB-like transcriptional mechanisms.
在肾素 - 血管紧张素系统激活的高血压患者中,心血管缺血事件可能更频繁地发生。我们检验了血管紧张素II(Ang II)可能通过增加血管炎症基因如血管细胞黏附分子-1(VCAM-1)的表达来促进动脉粥样硬化的假说。
用去甲肾上腺素或Ang II灌注6天的大鼠出现相似的高血压反应,但只有接受Ang II治疗的大鼠主动脉VCAM-1蛋白和mRNA表达显著增加。口服氯沙坦治疗(50 mg·kg⁻¹·d⁻¹)可抑制Ang II诱导的高血压和主动脉VCAM-1 mRNA表达。Ang II处理显著增加培养的大鼠主动脉平滑肌细胞(RASMCs)中VCAM-1 mRNA的表达。Ang II还诱导核NF-κB样结合活性并反式激活NF-κB驱动的VCAM-1启动子。氯沙坦和蛋白酶体抑制剂可阻断Ang II诱导的NF-κB激活和VCAM-1 mRNA积累。RASMCs中IkappaB-α的过表达抑制了Ang II诱导的VCAM-1启动子反式激活。
Ang II可能通过蛋白酶体依赖性、NF-κB样转录机制激活VCAM-1,从而促进动脉粥样硬化的发生。